The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBVIE INC | COM | 00287Y109 | 36,343 | 477,000 | SH | SOLE | 477,000 | 0 | 0 | ||
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 15,083 | 357,000 | SH | SOLE | 357,000 | 0 | 0 | ||
| ACCELERON PHARMA INC | COM | 00434H108 | 14,918 | 166,000 | SH | SOLE | 166,000 | 0 | 0 | ||
| AERIE PHARMACEUTICALS INC | COM | 00771V108 | 6,845 | 507,000 | SH | SOLE | 507,000 | 0 | 0 | ||
| AIMMUNE THERAPEUTICS INC | COM | 00900T107 | 5,883 | 408,000 | SH | SOLE | 408,000 | 0 | 0 | ||
| ALECTOR INC | COM | 014442107 | 17,229 | 714,000 | SH | SOLE | 714,000 | 0 | 0 | ||
| ALEXION PHARMACEUTICALS INC | COM | 015351109 | 14,366 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
| ALLERGAN PLC | SHS | G0177J108 | 7,084 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 6,499 | 1,624,800 | SH | Call | SOLE | 1,624,800 | 0 | 0 | |
| ANIKA THERAPEUTICS INC | COM | 035255108 | 4,857 | 168,000 | SH | SOLE | 168,000 | 0 | 0 | ||
| ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 6,757 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
| AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 17,151 | 1,182,000 | SH | SOLE | 1,182,000 | 0 | 0 | ||
| AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 3,033 | 382,000 | SH | SOLE | 382,000 | 0 | 0 | ||
| AXSOME THERAPEUTICS INC | COM | 05464T104 | 11,590 | 197,000 | SH | SOLE | 197,000 | 0 | 0 | ||
| BIOGEN INC | COM | 09062X103 | 19,616 | 62,000 | SH | SOLE | 62,000 | 0 | 0 | ||
| BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 18,376 | 540,000 | SH | SOLE | 540,000 | 0 | 0 | ||
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 25,519 | 302,000 | SH | SOLE | 302,000 | 0 | 0 | ||
| BIOXCEL THERAPEUTICS INC | COM | 09075P105 | 4,716 | 211,000 | SH | SOLE | 211,000 | 0 | 0 | ||
| CARDINAL HEALTH INC | COM | 14149Y108 | 24,210 | 505,000 | SH | SOLE | 505,000 | 0 | 0 | ||
| CATALENT INC | COM | 148806102 | 21,351 | 411,000 | SH | SOLE | 411,000 | 0 | 0 | ||
| CHARLES RIV LABS INTL INC | COM | 159864107 | 7,194 | 57,000 | SH | SOLE | 57,000 | 0 | 0 | ||
| CHEMOCENTRYX INC | COM | 16383L106 | 9,482 | 236,000 | SH | SOLE | 236,000 | 0 | 0 | ||
| CIGNA CORP NEW | COM | 125523100 | 11,517 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
| COHERUS BIOSCIENCES INC | COM | 19249H103 | 6,196 | 382,000 | SH | SOLE | 382,000 | 0 | 0 | ||
| COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 278 | 17,000 | SH | SOLE | 17,000 | 0 | 0 | ||
| CVS HEALTH CORP | COM | 126650100 | 16,434 | 277,000 | SH | SOLE | 277,000 | 0 | 0 | ||
| DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | 13,499 | 3,824,000 | SH | SOLE | 3,824,000 | 0 | 0 | ||
| ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 6,464 | 205,000 | SH | SOLE | 205,000 | 0 | 0 | ||
| EXELIXIS INC | COM | 30161Q104 | 18,701 | 1,086,000 | SH | SOLE | 1,086,000 | 0 | 0 | ||
| GILEAD SCIENCES INC | COM | 375558103 | 14,952 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| HORIZON THERAPEUTICS PUB LTD | SHS | G46188101 | 9,863 | 333,000 | SH | SOLE | 333,000 | 0 | 0 | ||
| HUMANA INC | COM | 444859102 | 10,363 | 33,000 | SH | SOLE | 33,000 | 0 | 0 | ||
| IMMUNOMEDICS INC | COM | 452907108 | 6,646 | 493,000 | SH | SOLE | 493,000 | 0 | 0 | ||
| IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 7,416 | 735,000 | SH | SOLE | 735,000 | 0 | 0 | ||
| KADMON HLDGS INC | COM | 48283N106 | 11,849 | 2,828,000 | SH | SOLE | 2,828,000 | 0 | 0 | ||
| LIGAND PHARMACEUTICALS INC | COM NEW | 53220K504 | 7,417 | 102,000 | SH | SOLE | 102,000 | 0 | 0 | ||
| MCKESSON CORP | COM | 58155Q103 | 32,868 | 243,000 | SH | SOLE | 243,000 | 0 | 0 | ||
| MERCK & CO. INC | COM | 58933Y105 | 37,854 | 492,000 | SH | SOLE | 492,000 | 0 | 0 | ||
| MINERVA NEUROSCIENCES INC | COM | 603380106 | 5,960 | 990,000 | SH | Call | SOLE | 990,000 | 0 | 0 | |
| MINERVA NEUROSCIENCES INC | COM | 603380106 | 2,674 | 444,200 | SH | SOLE | 444,200 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 22,677 | 295,000 | SH | SOLE | 295,000 | 0 | 0 | ||
| MODERNA INC | COM | 60770K107 | 10,932 | 365,000 | SH | SOLE | 365,000 | 0 | 0 | ||
| MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 21,216 | 780,000 | SH | SOLE | 780,000 | 0 | 0 | ||
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 8,482 | 98,000 | SH | SOLE | 98,000 | 0 | 0 | ||
| REGENERON PHARMACEUTICALS | COM | 75886F107 | 24,415 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 7,826 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
| SEATTLE GENETICS INC | COM | 812578102 | 66,920 | 580,000 | SH | SOLE | 580,000 | 0 | 0 | ||
| SEATTLE GENETICS INC | COM | 812578102 | 13,581 | 117,700 | SH | Call | SOLE | 117,700 | 0 | 0 | |
| SUNESIS PHARMACEUTICALS INC | COM | 867328700 | 1,788 | 4,310,000 | SH | SOLE | 4,310,000 | 0 | 0 | ||
| UNIQURE NV | SHS | N90064101 | 11,246 | 237,000 | SH | SOLE | 237,000 | 0 | 0 | ||
| VERASTEM INC | COM | 92337C104 | 7,367 | 2,790,698 | SH | SOLE | 2,790,698 | 0 | 0 | ||
| VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 8,090 | 34,000 | SH | SOLE | 34,000 | 0 | 0 | ||